High mortality during direct acting antiviral therapy for hepatitis C patients with Child's C cirrhosis: Results of the Irish Early Access Programme
- PMID: 27130842
- DOI: 10.1016/j.jhep.2016.03.022
High mortality during direct acting antiviral therapy for hepatitis C patients with Child's C cirrhosis: Results of the Irish Early Access Programme
Comment in
-
Reply to: "High mortality during direct acting antiviral therapy for hepatitis C patients with Child's C cirrhosis: Results of the Irish Early Access Programme".J Hepatol. 2016 Aug;65(2):448. doi: 10.1016/j.jhep.2016.04.011. Epub 2016 Apr 27. J Hepatol. 2016. PMID: 27132169 No abstract available.
Comment on
-
Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis.J Hepatol. 2016 Jun;64(6):1224-31. doi: 10.1016/j.jhep.2016.01.029. Epub 2016 Jan 30. J Hepatol. 2016. PMID: 26829205
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical